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Friend leukemia virus-infected erythroid precursor cells grow m  suspension culture 
as  undifferentiated  hemocytoblasts,  but  undergo  differentiation  along  the  erythroid 
pathway when they are treated with dimethyl sulfoxide (DMSO) 1 (1) or other aprotic 
solvents (2,3), or butyric acid (4). DMSO-treated leukemia cells show the characteristics 
of the  erythroid  cells  as judged  by the  histochemical  staining  of hemoglobin in  the 
cytoplasm (1), the incorporation of 59Fe into heme (1), the fluorometric quantitation of 
heme (2), the absorption spectra of the cell extract (1), and the characteristic electropho- 
retic migration pattern of mouse hemoglobin on polyacrylamide gels (5).  In addition, 
DMSO-treated  cells form a  mouse  erythrocyte membrane antigen  by the  4th  day of 
culture  (6)  and  become  agglutinable  with  phytohemagglutinin  (7). Thus  these  cells 
represent a  very useful model of erythroid differentiation in tissue culture and permit 
studies of the process of differentiation in continuously dividing erythroid cells which are 
otherwise not possible when using cells of normal hematopeietic origin. 
Ross et al. (8) on the one hand, have shown that RNA sequences complementary to 
transcripts of mouse globin messenger RNA (mRNA) can be detected in Friend leukemia 
cells starting 2 days after treatment with DMSO. On the other hand, the appearance of 
hemoglobin takes place only 3-4 days after the DMSO treatment.  The length of time 
between the appearance of globin mRNA and of hemoglobin suggests the possibility of a 
requirement for some other factor(s) before the appearance of synthesis of hemoglobin 
molecules.  Since heme is an obligatory component for the formation of hemoglobin, it 
seemed of considerable interest to assess the capacity of cells to make heme during the 
erythroid differentiation of the leukemia cells by assaying activities of certain enzymes of 
the heme pathway and the concentration of heme itself in such cells. 
In this paper, data are reported on the heme concentrations and the activities 
of certain enzymes of the heme biosynthetic pathway both in undifferentiated 
cells and in differentiated cells. The highly sensitive assays developed for these 
enzymes have permitted me to make the novel finding that a sequential induc- 
tion  of enzymes of the heme biosynthetic chain  takes place during  erythroid 
differentiation of Friend leukemia cells. Evidence is presented that a sequential 
induction  of these enzymes  may be due to  sequential  activation  of genes for 
these enzymes in the cells. 
* Supported by a grant from the American Cancer Society,  Inc.  (BC-180). 
Recipient of  a Career Scientist  Award (I-768)  of  the Health Research Council of  the City of 
New York. 
1  Abbreviations used in this paper: ALA, 8-aminolevulinic acid; BrdU, 5-bromo-2'-deoxyuridine; 
DMSO,  dimethyl sulfoxide; URO, uroporphyrinogen-I. 
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Materials and Methods 
Friend Leukemia Cells.  A clonal line of Friend leukemia cells (T3-C1-2) was obtained through 
the courtesy of Doctors  Y.  Ikawa  and P.  Leder of the National Institute of Child Health and 
Human Development, National Institutes of Health, Bethesda, Md. This line hardly differentiates 
spontaneously,  but  has  been  reported  to  synthesize  globin  mRNA  (8),  hemoglobin  (8),  and 
erythrocyte membrane antigen (6) after treatment with DMSO. 
Cells were grown in 250 ml plastic flasks (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) 
containing 10 ml of Ham F12 medium supplemented with 10% heat-inactivated fetal bovine serum. 
Penicillin (100 U/ml) and streptomycin (100 ~g/ml) were also added to the medium. Phenol red was 
not included in the medium since it interferes with the fluorescence assay of heine. Mycostatin (25 
~g/ml) was found inhibitory to the differentiation process and was excluded from the medium. The 
cultures were incubated at 37°C  under a  humidified atmosphere of 95% air-5% CO2.  On the day 
DMSO was to be added, the Cells were transferred to a fresh medium at 5  x  104 cells/ml. DMSO 
(spectral grade; Eastman Organic Chemicals Div., Eastman Kodak Co.,  Rochester N.  Y.) was 
then  added  to  a  final concentration  of 1.5%.  The  cells  were  incubated  as  indicated  in  each 
experiment for up to 6  days,  and were then centrifuged and assayed in duplicate.  5-bromo-2'- 
deoxyuridine  (BrdU) and thymidine were obtained from Calbiochem,  San Diego,  Calif.  Fetal 
bovine serum (Grand Island Biological Co., Grand Island, N. Y.) which had been previously tested 
for its capacity to support a good erythroid differentiation was heat inactivated at 56°C for 30 rain. 
The complete growth medium was sterilized by filtration through a  0.45 ~m Millipore filter and 
stored at 4°C. 
Assay for &Aminolevulinic  Acid (ALA)-Synthetase  Activity.  The activity of ALA synthetase 
was determined by a  minor modification of the radiochemical assay of Strand et al. (9) using 107 
cells per assay. The incubation mixture contained 100 mM glycine, 50 mM Tris-HCl, pH 7.4, 20 
mM  MgCI~,  10  mM  EDTA,  1  mM  pyridoxal  5'-phosphate,  1  mM  dithiothreitol,  10  mM  Na 
malonate, 5 mM Na vL-malate, 5 mM Na arsenate, 2.5/~g/ml antimycin A, 25 mM ATP,  1 mM 
coenzyme A, 12.5 mM Na succinate, cells, 2 units of succinyl CoA synthetase (1 unit =  1 p~-nol 
succinohydroxamate/mg protein, 37°C, h), and 5/~Ci of [1,4-14C]succinic acid (sp act 24 mCi/mmol) 
per assay. The final vol of the assay mixture was adjusted to 400 ~1 and quickly frozen and thawed 
in dry-ice acetone three times; the mixture was then incubated for 20 rain at 37°C.  The reaction 
was stopped with one volume of 8% TCA. ALA was isolated by using DOWEX column chromatog- 
raphy (Dow Chemical Co., Midland, Mich.) (9). 
Assay for ALA-Dehydratase  Activity.  The activity of ALA dehydratase was assayed spectre- 
photometrically by the  micromethod of Sassa  et  al.  (10)  using cells derived  from a  1  ml cell 
suspension. Cells were frozen and thawed three times in dry-ice acetone before the incubation. 
This procedure was necessary to obtain maximum activity of the enzyme. 
Assay for Uroporphyrinogen-I (URO)-Synthetase Activity.  This enzyme assay was carried out 
by the microfiuorometric method of Sassa et al. (11) using cells derived from a 1 ml cell suspension 
per assay.  Cells were also frozen and thawed before the incubation as described above. 
Fluorometric Assay of Heine.  Heine concentration was determined fluorometrically with a 
minor modification of the assay described by Morrison (12). The method is based on the conversion 
of the heine moiety of hemoglobin to its fluorescent porphyrin derivative by the removal of heme 
iron under acidic reducing conditions. Cell suspensions containing 10  ~ cells were transferred to a 1 
ml disposable glass tube (6  x  50 ram, Kimble Products Div., Owens-Illinois, Inc., Toledo, Ohio). 
The tubes were then centrifuged at 2,000g for 5 rain. After removal of the supernates, 500 p] of 2 M 
oxalic acid was added to the pellet. The mixture was shaken vigorously and immediately heated 
for 30 rain at 100°C by inserting the lower half of the tube into an aluminum block which had been 
placed in a heating dry-bath (Thermolyne Corp., Dubuque, Iowa). Small marbles were placed on 
top of the tube to minimize evaporation. A tissue blank containing cells with the oxalic acid but 
without heating was run to check for the presence of endogenous perphyrins in the cell. Standards 
were made by adding 10 ~1 of hemin solution prepared in 1% (wt/vol) bovine serum albumin-0.01 N 
KOH-50% (vol/vol) methanol to 2 M oxalic acid solution, then heating as above. 
After cooling, fluorescence was determined in a  Hitachi--Perkin Elmer MPF2A fluorescence 
spectrophotometer (Perkin-Elmer Corp.,  Hitachi--Perkin Elmer Instruments,  Mountain View, 
Calif.)  equipped  with  an  R-446  UR  photomultiplier.  The  tubes  were  inserted  directly  into  a 
semimicrocell holder with capacity of accepting four tubes (13). The exciting light was at 400 nm SHIGERU  SASSA  307 
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Fro. i.  Changes in  the activity  of  ALA synthetase,  ALA dehydratase, and URO  synthe- 
tase in Friend leukemia cells  after  DMSO  treatment. Cells  (T3-C1-2)  were grown in the 
absence (O) or in the presence of 1.5% DMSO  (@). There was approximately a 20-fold 
increase in cell  number at the end of  the experiment.  (Q),  the time when the increase 
became significant  over control.  Data are the mean of  duplicate - triplicate  assays. 
through blue Zeiss  BG-2 and  BG-4 filters (Carl  Zeiss,  Inc.,  New  York),  and the  fluorescence 
emission was determined at  662  nm through a  red Coming 2-63  filter (Corning Glass Works, 
Science Products Div.,  Coming,  N.  Y.).  The response of the spectrophotometer was calibrated 
against a  standard rhodamin B solution (40 ng/ml) in ethylene glycol (14). 
The fluorescence generated from berne was strictly linear between 10-' and 10  -6 M. Under these 
conditions, 1 p2Vl heme gave 15,200 fluorescence units at 662 nm. 2 The lowest detection ofheme in a 
0.5  ml mixture by this method  was  0.5  x  10 -~2 mol.  Fluorescence yield  was  linear with cell 
concentrations up to approximately 2  ×  105 cells per assay for both untreated and DMSO-treated 
cells, but it reached a plateau at cell concentrations greater than 2 x  10  ~. 1 x  l0  s cells were used to 
determine heme concentration in all assays. 
Incorporation of 14C-ALA into Heine.  Cells were grown in the presence of 0.5/zCi of "C-ALA at 
a concentration of 2 x  10  -s M and portions of the cell suspension were analyzed for "C-heine. Cells 
were washed three times in Ham F12 medium and 25 ~1 of carrier hemoglobin (10 g/100 ml) was 
added.  Heine was then extracted with cyclohexanone at pH  2  (15);  the extract was dried on a 
planchette and counted by a  gas flow counter (Nuclear-Chicago Corp.,  Des Plaines, Ill.) with a 
counting efficiency of 30%. 
Incorporation of SFe into Heine.  Cells were incubated with 0.15/~Ci/ml of ~Fe (ferrous citrate, 
sp  act  20Ci/g  iron) and heine  was  extracted  as  described above.  S~Fe-heme was  counted in a 
Packard Autogamma Spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.). 
Results 
Induction of  ALA-Synthetase, ALA-Dehydratase, and URO-Synthetase activ- 
ities by DMSO.  Activities  of ALA synthetase,  ALA dehydratase,  and URO 
synthetase  were  low  but  detectable  in  untreated  cells.  This  is  in  striking 
contrast  to globin mRNA which is reported  to be essentially undetectable  in 
untreated  cells  (8).  The  levels  of these  three  enzymes in the heine pathway 
remained constant  in untreated  cells  during the culture period  (Fig.  1)  and 
throughout many passages.  This confirms  that  differentiation  of these  cells 
toward the erythroid pathway scarcely takes place spontaneously. 
Fluorescence unit  is  defined  as  1/100  division  of  the  full  scale  recording  on  a 9  inch  chart  at  the 
maximal sensitivity.  Essentially  all  the  heme was  converted to  fluorescent  porphyrins under  these 
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Fro.  2.  Changes in the uptake of ALA and iron (Fe) into home, and heine concentration. 
Cells (T3-C1-2) were grown in the absence of (©) or in the presence of 1.5% DMSO (0). Data 
are the mean of duplicate assays. 
In  striking  contrast  to  the  untreated  cells,  the  cells  treated  with  DMSO 
showed a  significant increase in ALA-synthetase activity by the end of the 1st 
day and ALA-dehydratase  activity by 1.5 days (Fig.  1).  The  activity of URO 
synthetase showed a  significant increase only after the 2nd day, approximately 
1/2 day later than that of ALA dehydratase (Fig. 1). The difference in the time of 
appearance ALA dehydratase an  d URO synthetase was consistent and signifi- 
cant since it was always observed when assaying the enzyme activity in the cell 
suspensions obtained from the same culture flask. 
Increase in Home Concentration by DMSO.  The total heme concentration in 
untreated  cells remained  approximately  constant  (0.01  -  0.02  nmol/10 e cells) 
throughout the culture period as well as after many passages over more than a 
year of study. In cells grown in the presence of DMSO, however, a  significant 
increase of home concentration became apparent after 4 days of culture (Fig. 2) 
and a distinct reddish color was readily observed in the pelleted cells by the 6th 
day. Approximately 0.5 -  1.0 nmol heme/108 cells was found by the 6th day, that 
is, 50 times more heme per cell than in the untreated cells. 
Incorporation of 14C-ALA into Home.  In order to determine when the leuke- 
mia cells begin to incorporate ALA into home,  14C-ALA uptake into home was 
investigated.  Untreated cells showed a constant level of 14C-ALA incorporation 
into  heme  from  the  2nd  day  to  the  5th  day  (Fig.  2).  DMSO-treated  cells, 
however, showed an increase in ~4C-ALA utilization into home but only after 4 
days of cultures (Fig. 2). Since activities of ALA dehydratase and URO synthe- 
tase had already increased by the end of the 2nd day of cultures, ALA incorpora- 
tion  into home appears to be limited by an enzymatic step(s) which develops 
later than the appearance of URO-synthetase activity. 
59Fe Incorporation  into Home.  Untreated  cells showed an almost constant 
ability to incorporate  5'Fe into home throughout the culture period.  However, 
DMSO-treated cells exhibited a significant rise in 5'Fe incorporation into home 
after the 4th day (Fig.  2).  Since this curve of incorporation  of 5'Fe essentially 
overlaps with that of 14C-ALA incorporation into home and meets that of home 
concentration as determined fluorometrically, the limiting step for ALA utiliza- SHIGERU  SASSA 
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FIG. 3.  The effect  of  actinomycin  D on  ALA dehydratase  and URO synthetase  in  DMSO- 
treated Friend  leukemia cells.  Cells  (T3-C1-2)  were pretreated  with 1.5% DMSO, and 
actinomycin  D (0.3  /~g/ml)  was added at the 62nd h after  the addition  of  DMSO. Enzyme 
activities  were  determined  during  the  following  8  h.  (O),  1.5%  DMSO. (@),  1.5%  DMSO plus 
0.3/zg/ml  actinomycin  D. Data are  the  mean of  duplicate  assays. 
tion is almost certainly related to the development of  ferrochelatase,  the termi- 
nal step in heine biosynthesis.  The increase in ALA  incorporation and 59Fe 
incorporation  into heine essentially  occurred  at the same  time and then a 
significant increase in heine concentration was observed in the cells. 
Effect of Actinomycin  D  on  the Activities  of ALA  Dehydratase  and  URO 
Synthetase.  In order to investigate whether DMSO-induced changes of heme 
pathway enzymes are due to increased synthesis of specific mRNA's for these 
enzymes  or  due  to  an  increase  in  translational  efficiency  of  pre-existing 
mRNA's, cells which had been treated with  1.5%  DMSO were incubated with 
actinomycin D. Since actinomycin D is toxic for cell multiplication,  this experi- 
ment was carried out between the 62nd and  70th h  after the treatment  with 
DMSO. The concentration of actinomycin D used in this experiment (0.3 p4g/ml) 
has been found to inhibit RNA synthesis by 90% in the same clonal line of cells 
(16). 
As shown in Fig. 3, when actinomycin D was added to the culture at the 62nd 
h  after  DMSO  treatment,  it  inhibited  cell  growth  almost  completely.  Cell 
viability,  however,  was  not  appreciably  affected  as judged  by  trypan  blue 
exclusion (17). At this time ALA-dehydratase activity increased rapidly in the 
absence  of actinomycin  D,  whereas  in  the  presence  of actinomycin  D,  the 310  SEQUENTIAL  INDUCTION  OF  HEME  PATHWAY  ENZYMES 
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FIo. 4.  Inhibition  of  DMSO-induced changes by BrdU. Cells  were grown in  the  presence of 
1.5% DMSO.  BrdU (10  -5 M) was added as indicated in the figure;  the enzyme activity  and 
heine concentration were  then  determined on  the 6th day. (©),  ALA dehydratase. (A),  URO- 
synthetase. (D),  heine. Data are the mean of  duplicate assays. 
increase in ALA-dehydratase  activity  was greatly suppressed. Increases in 
URO-synthetase activity  were also  prevented by actinomycin D. These results 
suggest that  the increases  in the enzymes in DMSO-treated cells  are probably 
due to incrased  mRNA  synthesis  for  these enzymes in the heine pathway. 
Effect  of  BrdU on the Development of  ALA Dehydratase, URO Synthetase, 
and Heine Concentration.  BrdU has been reported  to inhibit  the formation of 
globin  mRNA  (18)  and hemoglobin (19)  in  DMSO-treated Friend leukemia cells. 
In order to investigate  whether BrdU prevents the increase  in the activities  of 
ALA dehydratase and URO  synthetase,  and in  heme concentration,  BrdU was 
added to give  a final  concentration of 10  -s M  on days 0, 1, 2, 3, 4, and 5 after 
DMSO  was introduced into  the cultures;  the activities  of  ALA dehydratase and 
URO synthetase and  heine concentration  were  determined on  the  6th  day.  When 
BrdU was added on days 0 and 1, it  almost completely blocked the subsequent 
increases of ALA-dehydratase activity  and heine concentration and inhibited 
the increase  of  URO-synthetase activity  by approximately 80% (Fig.  4). BrdU, 
however, partially  lost  its inhibitory  effects  on the development of these en- 
zymes and heme when it was added on the 2nd day or later after DMSO 
addition.  When the analogue was added at  day 5, the inhibition  by BrdU of  the 
increases of  ALA  dehydratase and heine was less  than 10% and that of  URO 
synthetase was approximately 25% (Fig.  4).  These data suggest,  though they do 
not  conclusively  establish,  that  proper  transcription  is  necessary for  cell  differen- 
tiation and the sequential induction of heine pathway enzymes which takes 
place in these cells. 
Effects of Thymidine on the Inhibition by BudU.  When thymidine (7 ×  10  -5 
M) was added in addition to DMSO and BrdU, the inhibitory effects of BrdU on 
the increases in activities of ALA dehydratase and URO synthetase and the 
heme concentration were prevented (Fig. 5). The effect of thymidine was great- SHIGERU  SASSA  311 
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FIG. 5.  Reversal of the BrdU inhibition  by thymidine (TdR) Cells  were grown in the 
presence of  DMSO  (1.5%)  and BrdU (10  -5 M). Thymidine (7 × 10  -s  M) was then added as 
indicated  in the figure.  The enzyme activity  and heme concentration  were determined on 
the  6th  day. (C)),  ALA-dehydratase. (A),  URO-synthetase. (n),  herne.  Data are  the  mean of 
duplicate  assays. 
est when it was added on days 0, I, and 2; its ability  to reverse inhibition  by 
BrdU was greatly  reduced when it  was added  on  day 3  or  later.  Uridine (7 × 10  -~ 
M) had no effect  on the BrdU inhibition. 
Discussion 
The results of the present study indicate that a sequential induction of 
enzymes of  the heine biosynthetic  pathway occurs  during erythroid  differentia- 
tion  of  Friend leukemia cells  according to  the biosynthetic  order  of  the enzymes 
in the pathway. It is clear  from this  study that the increase in hemoglobin is 
preceded by a sequential increase  of  the enzyme activities  of  the heine biosyn- 
thetic  pathway. An early  increase  in  ALA-synthetase activity  in  these  cells  was 
found within 24 h after  DMSO  treatment. Ebert and Ikawa (20)  have also 
reported  the early  increase  in  ALA-synthetase activity  in  these  cells  by  the  28th 
h after  DMSO  treatment. 
It was found in this  study that the activity  of ALA  dehydratase  and URO 
synthetase in these cells  increased within 36 and 48 h after  DMSO  treatment, 
respectively.  Thus, increases  in ALA synthetase and ALA dehydratase in  these 
cells  take place as early  as the appearance of globin mRNA  which has been 
reported  by Ross et  al.  (8)  and  precede the increase  in  hemoglobin concentration 
by at least 2 days. This fact  raises a question whether globin mRNA  is not 
translated  into  globin  peptides  or  the formation of  heine is  not  completed by  the 
4th day after DMSO  treatment. It has been suggested that undifferentiated 
Friend leukemia cells contain a  translational repressor which might possibly 
inhibit the translation of globin mRNA (21). However, free globin appears to be 
made within 2 days of DMSO treatment (W. Scher, personal communication), 
suggesting that  inhibition of translation  of globin  mRNA is  not complete. 
Moreover, the studies reported in this paper clearly show that ~Fe incorporation 
into heme increases only on the 4th day after DMSO treatment, suggesting that 312  SEQUENTIAL  INDUCTION  OF  HEME  PATHWAY  ENZYMES 
ferrochelatase must be limiting in heme formation. In agreement with this idea, 
14C-ALA incorporation into heme increased also 4 days after DMSO treatment. 
Thus, the lag between the appearance of globin mRNA and hemoglobin can be 
attributed  to the  late  increase  in ferrochelatase,  the  terminal  enzyme in  the 
heme biosynthetic pathway. 
The increase in activities of the heme pathway enzymes in cells induced to 
undergo erythroid differentiation apparently depends on de novo RNA synthe- 
sis, since actinomycin D blocked these induced changes when added on the 3rd 
day after  DMSO treatment.  Moreover,  DMSO-induced  changes  of the  heme 
pathway enzymes appear to require DNA synthesis since they were prevented 
nearly completely when BrdU was added to the culture and the BrdU inhibition 
was completely overcome by thymidine but not by uridine.  These facts suggest 
that the BrdU effect on the suppression of induced changes may be mediated 
through incorporation of the analogue into DNA. It has been also reported by 
McClintock et al. (22) using a synchronization technique that the Friend leuke- 
mia  cells require  two rounds  of DNA synthesis in  the presence  of DMSO to 
differentiate. 
In studies of the heme pathway of Staphylococcus aureus, Tien and White (23) 
have found by genetic mapping that genes specifying for enzymes of the heme 
pathway are arranged  in the order of their sequence in the biosynthetic path- 
way. In addition the genes are tightly linked and are co-transducible (23). It is 
thus  tempting  to  postulate  that  the  genes  coding  for  enzymes  of the  heme 
biosynthetic pathway may also be arranged in a sequential fashion in mamma- 
lian  hemopoietic  stem  cells  and  become  activated  sequentially  once  DMSO 
triggers the first gene of the pathway. This hypothesis predicts transcriptional 
activation of the genes rather than post-transcriptional modification of mRNA's. 
In support of this idea, as shown in this study as well as in other studies (16), if 
actinomycin  D  was  also  present  in  the  growth  medium  the  heme  pathway 
enzymes  did  not  increase.  Also,  in  cells  in  which  proper  transcription  was 
prevented due to BrdU, these enzyme activities of the heme pathway were not 
increased. 
It is not clear how DMSO initiates the first event of the sequential changes. 
DMSO may alter membrane properties leading to triggering for the "induction." 
DMSO itself may reach the nucleus of the cell to directly open up the chromo- 
somal genes. Recent evidence in other systems also suggest the possibility that 
DMSO may directly act on the chromosomes to cause increased transcription 
(24-27). 
From the data presented in this report, it may be concluded that a sequential 
induction of enzymes of the heme biosynthetic pathway occurs during erythroid 
cell differentiation in Friend leukemia cells. Our previous work (28) also indi- 
cates that similar sequential induction of the heme biosynthetic pathway may 
occur during  erythropoietin-induced  erythroid differentiation  in the  spleen of 
polycythemia mice and that the induction of ALA synthetase in the spleen by 
erythropoietin is also prevented by actinomycin D. It has similarly been found 
during the development of  fetal mouse liver that ALA synthetase, ALA dehydra- 
tase, and ferrochelatase appear to increase sequentially (29). Since these latter 
two examples are of erythroid differentiation in a normal hematopoietic tissue, SHIGERU  SASSA  313 
it may generally be suggested that sequential induction of the heme pathway 
enzymes occurs  when  the  stem  cell,  either  normal  or  virally transformed, 
differentiates into the erythroid pathway. 
Summary 
The  process  of erythroid differentiation in  mouse  Friend  leukemia virus 
transformed cells  (T3-C1-2)  was  examined by  following changes  in  several 
enzyme activities of the heme biosynthetic pathway and in heme concentration 
while the cells were undergoing erythroid differentiation after treatment with 
dimethylsulfoxide. Untreated cells on the one hand, have a limited capacity for 
spontaneous  differentiation.  On  the  other  hand,  dimethylsulfoxide(DMSO)- 
treated cells showed an increase in the activities of 8-aminolevulinic acid (ALA) 
synthetase, ALA dehydratase, uroporphyrinogen-I synthetase, ferrochelatase, 
and heine concentration by days 1, 1.5,  2, 4, and 4, respectively. 
The increase of the heme pathway enzymes and heme concentration followed 
the  order  of these  enzymes or  products  as  they are  arranged  in  the  heme 
biosynthetic pathway. These changes induced by DMSO  were effectively in- 
hibited  by  treatment with  actinomycin D,  suggesting that  continued  RNA 
synthesis is  required for the differentiation process.  5-bromo-2'-deoxyuridine 
(BrdU)  (10 -s M)  inhibited the  DMSO-induced changes of the heine pathway 
enzymes. BrdU was most effective when it was present during the first 2 days of 
cell culture. It gradually lost its inhibitory effect when added after the 3rd day or 
later. The BrdU-mediated inhibition was completely overcome by the addition of 
thymidine (7  ×  10  -s M), but not by uridine (7 ×  10  -5 M). All these data suggest 
that a  sequential induction of the heme pathway enzyme takes place during 
erythroid  differentiation of Friend  leukemia cells,  and  that  the  sequential 
induction of the enzymes may be due to a sequential activation of genes coding 
for these enzyme activities. 
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